Phase III RNA-DC trial

A worldwide first randomized adjuvant trial in a subgroup of high risk melanoma patients (monosomy 3) using autologous DC transfected with amplified total tumor RNA derived from patients' uvea melanomas was to be started in 2009 and data will become available.

created over 14 years ago (22 February 2010)    last modified over 11 years ago (25 March 2013)   [ RDF ]   [ RelFinder ]